These studies hopefully should help us to establish a possible role of the altered activation (modification) of several parts of complement, the different fragmentation of ITIH4 and the endorepellin fragment in the promotion of the pathological clone in MDS. The gene discussed is HSPG2; the disease is myelodysplastic syndrome.